List of Tables
Table 1. Global Oncology Companion Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Polymerase Chain Reaction (PCR)
Table 3. Key Players of Next-Generation Sequencing (NGS)
Table 4. Key Players of Immunohistochemistry (IHC)
Table 5. Key Players of In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Table 6. Key Players of Others
Table 7. Global Oncology Companion Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Oncology Companion Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Oncology Companion Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Oncology Companion Diagnostic Market Share by Region (2019-2024)
Table 11. Global Oncology Companion Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Oncology Companion Diagnostic Market Share by Region (2025-2030)
Table 13. Oncology Companion Diagnostic Market Trends
Table 14. Oncology Companion Diagnostic Market Drivers
Table 15. Oncology Companion Diagnostic Market Challenges
Table 16. Oncology Companion Diagnostic Market Restraints
Table 17. Global Oncology Companion Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Oncology Companion Diagnostic Market Share by Players (2019-2024)
Table 19. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Companion Diagnostic as of 2023)
Table 20. Ranking of Global Top Oncology Companion Diagnostic Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Oncology Companion Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Companion Diagnostic Product Solution and Service
Table 24. Date of Enter into Oncology Companion Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Companion Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Oncology Companion Diagnostic Revenue Market Share by Type (2019-2024)
Table 28. Global Oncology Companion Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Oncology Companion Diagnostic Revenue Market Share by Type (2025-2030)
Table 30. Global Oncology Companion Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Oncology Companion Diagnostic Revenue Market Share by Application (2019-2024)
Table 32. Global Oncology Companion Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Oncology Companion Diagnostic Revenue Market Share by Application (2025-2030)
Table 34. North America Oncology Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Oncology Companion Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Oncology Companion Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Oncology Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Oncology Companion Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Oncology Companion Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Oncology Companion Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Oncology Companion Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Oncology Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Oncology Companion Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Oncology Companion Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Oncology Companion Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Oncology Companion Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 49. Agilent Technologies, Inc. Company Detail
Table 50. Agilent Technologies, Inc. Business Overview
Table 51. Agilent Technologies, Inc. Oncology Companion Diagnostic Product
Table 52. Agilent Technologies, Inc. Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 53. Agilent Technologies, Inc. Recent Development
Table 54. Illumina, Inc. Company Detail
Table 55. Illumina, Inc. Business Overview
Table 56. Illumina, Inc. Oncology Companion Diagnostic Product
Table 57. Illumina, Inc. Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 58. Illumina, Inc. Recent Development
Table 59. Qiagen N.V. Company Detail
Table 60. Qiagen N.V. Business Overview
Table 61. Qiagen N.V. Oncology Companion Diagnostic Product
Table 62. Qiagen N.V. Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 63. Qiagen N.V. Recent Development
Table 64. Thermo Fisher Scientific Inc. Company Detail
Table 65. Thermo Fisher Scientific Inc. Business Overview
Table 66. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product
Table 67. Thermo Fisher Scientific Inc. Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 68. Thermo Fisher Scientific Inc. Recent Development
Table 69. F. Hoffmann-La Roche Ltd. Company Detail
Table 70. F. Hoffmann-La Roche Ltd. Business Overview
Table 71. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product
Table 72. F. Hoffmann-La Roche Ltd. Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 73. F. Hoffmann-La Roche Ltd. Recent Development
Table 74. ARUP Laboratories Company Detail
Table 75. ARUP Laboratories Business Overview
Table 76. ARUP Laboratories Oncology Companion Diagnostic Product
Table 77. ARUP Laboratories Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 78. ARUP Laboratories Recent Development
Table 79. Abbott Company Detail
Table 80. Abbott Business Overview
Table 81. Abbott Oncology Companion Diagnostic Product
Table 82. Abbott Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 83. Abbott Recent Development
Table 84. Myriad Genetics, Inc. Company Detail
Table 85. Myriad Genetics, Inc. Business Overview
Table 86. Myriad Genetics, Inc. Oncology Companion Diagnostic Product
Table 87. Myriad Genetics, Inc. Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 88. Myriad Genetics, Inc. Recent Development
Table 89. bioMérieux SA Company Detail
Table 90. bioMérieux SA Business Overview
Table 91. bioMérieux SA Oncology Companion Diagnostic Product
Table 92. bioMérieux SA Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 93. bioMérieux SA Recent Development
Table 94. Invivoscribe, Inc. Company Detail
Table 95. Invivoscribe, Inc. Business Overview
Table 96. Invivoscribe, Inc. Oncology Companion Diagnostic Product
Table 97. Invivoscribe, Inc. Revenue in Oncology Companion Diagnostic Business (2019-2024) & (US$ Million)
Table 98. Invivoscribe, Inc. Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Companion Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Oncology Companion Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. Next-Generation Sequencing (NGS) Features
Figure 5. Immunohistochemistry (IHC) Features
Figure 6. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) Features
Figure 7. Others Features
Figure 8. Global Oncology Companion Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Oncology Companion Diagnostic Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Pathology/Diagnostic Laboratory Case Studies
Figure 12. Academic Medical Center Case Studies
Figure 13. Oncology Companion Diagnostic Report Years Considered
Figure 14. Global Oncology Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Oncology Companion Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Oncology Companion Diagnostic Market Share by Region: 2023 VS 2030
Figure 17. Global Oncology Companion Diagnostic Market Share by Players in 2023
Figure 18. Global Top Oncology Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Companion Diagnostic as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Oncology Companion Diagnostic Revenue in 2023
Figure 20. North America Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Oncology Companion Diagnostic Market Share by Country (2019-2030)
Figure 22. United States Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Oncology Companion Diagnostic Market Share by Country (2019-2030)
Figure 26. Germany Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Oncology Companion Diagnostic Market Share by Region (2019-2030)
Figure 34. China Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Oncology Companion Diagnostic Market Share by Country (2019-2030)
Figure 42. Mexico Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Oncology Companion Diagnostic Market Share by Country (2019-2030)
Figure 46. Turkey Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Oncology Companion Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Agilent Technologies, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 49. Illumina, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 50. Qiagen N.V. Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 51. Thermo Fisher Scientific Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 52. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 53. ARUP Laboratories Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 54. Abbott Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 55. Myriad Genetics, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 56. bioMérieux SA Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 57. Invivoscribe, Inc. Revenue Growth Rate in Oncology Companion Diagnostic Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed